Noncommunicable Diseases in Saudi Arabia

Page 93

Calculating the Economic Burden of NCDs in Saudi Arabia  | 71

Although these estimates are based on fairly small sample sizes, they are consistent with data from the United States, which reveal that men with chronic disease work 6.1 percent fewer hours and women work 3.9 percent fewer hours than healthy workers (Stuckler et al. 2006). Monetizing absenteeism estimates based on the average wage of full-time workers (estimated to be Int$214 per day for Saudi nationals in 2018 international dollars) (GASTAT 2019) with one or more NCDs listed above reveals the following: • The total annual costs due to absenteeism in Saudi Arabia are Int$22.5 billion (2018 international dollars), which represent 1.21 percent of GDP in 2018. • This estimate does not take into account presenteeism, inability to have better paid jobs, early retirement, or productivity losses due to time spent caring for someone with NCDs. Only one study is available for Saudi Arabia that uses a bottom-up approach and assumptions regarding productivity loss from select NCDs, rate of population aging, incidence rate for each disease, and labor market projections (Rasmussen, Sweeny, and Sheehan 2015). It estimates that NCDs reduced GDP by at least 6.7 percent in Saudi Arabia in 2015 and predicts that NCDs will reduce GDP by 9.7 percent in 2030. Predictions for 2030 for other countries are similar: Singapore (6.7 percent), Japan (8.5 percent), and the United States (8.5 percent) (Rasmussen, Sweeny, and Sheehan 2015).

ECONOMIC BURDEN USING THE VALUE OF A STATISTICAL LIFE METHOD Cost-of-illness studies such as those described above tend to use market rates for health services and wages to quantify the burden. An alternative paradigm is the value of a statistical life, defined as the marginal rate of substitution between income (or wealth) and mortality risk. Using the VSL method, the value of premature death is inferred from real or hypothetical trade-offs that people willingly make (how much individuals are willing to pay to reduce the risk of death). These trade-offs typically entail taking on greater health risks in exchange for something of value, such as working in a smoke-filled bar or on an Alaskan fishing vessel, both risky occupations, in exchange for a higher salary. This higher salary can be interpreted as a risk premium and can be used to estimate the value of a statistical life. The main advantage of this approach is that it is most consistent with economic theory (that is, with utility maximization). The cost-of-illness approach accurately quantifies the burden of disease from an accounting perspective, but it does not take into account the changes in utility (value) that individuals may accrue from, say, not having to diet and exercise or the intrinsic value that people place on being alive. An additional advantage is that, unlike the cost-of-illness approach, the VSL approach can be used to generate unique estimates that each individual or set of individuals places on a particular risky scenario. These estimates, if aggregated across individuals, can be interpreted as the total statistical value of the loss due to a condition (for example, diabetes) and may include all direct, indirect, and intangible costs not easily measured, such as pain and suffering and premature mortality. This approach proceeds as follows (US EPA n.d.). Suppose that 100,000 people are asked how much they would be willing to pay to reduce their individual


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

9.2 Focus on three levels of prevention in the master plan

2min
page 226

sector

1min
page 228

Methodological approach Identification of stakeholders influencing and participating in

4min
pages 236-237

in Saudi Arabia

2min
page 241

diets in Saudi Arabia

2min
page 240

9.5 Benefits of targeting settings

1min
page 231

Prioritizing prevention over treatment

2min
page 225

References

30min
pages 208-218

plans

1min
page 223

Cost-effectiveness of screening

2min
page 198

Effectiveness of interventions to increase screening uptake

2min
page 201

8.6 Cost-effectiveness of screening

4min
pages 202-203

Diseases

1min
page 222

Cost-effectiveness of screening promotion interventions Information gaps, policy recommendations, and future research

2min
page 204

8.3 Recommendations regarding screening in comparative countries

4min
pages 196-197

Effectiveness of screening

2min
page 195

United States

2min
page 193

Screening in Saudi Arabia

2min
page 192

7.17 Evidence on cost-effectiveness of diet-related interventions

5min
pages 166-167

7.16 Evidence on cost-effectiveness of tobacco control interventions

3min
page 165

Cost-effectiveness of population-wide interventions

1min
page 164

7.13 Evidence on effectiveness of setting nutrition standards

2min
page 159

7.10 Evidence on effectiveness of BOP and FOP labeling

3min
page 157

e-cigarettes

2min
page 155

7.6 Evidence of effectiveness of e-cigarette tax

2min
page 154

Saudi Arabia

2min
page 152

Conclusions

1min
page 131

Saudi Arabia

2min
page 150

Saudi Arabia

2min
page 151

Noncommunicable Diseases

5min
pages 143-144

Plan

1min
page 128

Methodology

2min
page 124

References

17min
pages 116-122

Annex 5B: Methodology for estimating the impact of NCDs on HCI

2min
page 115

Annex 5A: Approaches to estimating the economic burden of NCDs

2min
page 114

North Africa

5min
pages 104-105

5.4 NCDs and human capital: Transmission mechanisms

15min
pages 107-112

Conclusions

2min
page 113

Summary and conclusions Annex 4A: Methodology for estimating the economic impact

2min
page 96

Economic burden using the value of a statistical life method Economic burden using the economic growth approach

5min
pages 93-94

References

4min
pages 61-62

3A.2 Adjusted decrease in salt intake and changes to systolic blood pressure in Saudi Arabia, by gender 3A.3 Prevalence estimates for overweight and obesity in Saudi Arabia, by age and

2min
page 78

Economic burden using the cost-of-illness method

2min
page 89

3 Disease prevalence in the employed working-age population in

3min
page 26

3.1 Years of life lost, years lost due to disability, and healthy life expectancy

3min
page 64

and 2019

1min
page 39

3.2 Definition of risk factors for at-risk populations

5min
pages 67-68

Conclusions

2min
page 76
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Noncommunicable Diseases in Saudi Arabia by World Bank Publications - Issuu